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Here we report two cases of isolation of Aurantimonas altamirensis from pleural fluid and blood.
The strains were identified by 16S rRNA gene sequencing. A. altamirensis appears to be a rare
pathogen involved in unusual infectious processes, and must be isolated and studied at the
molecular level for correct clinical diagnosis.
Case report
This paper reports two cases of isolation of Aurantimonas
altamirensis from two human clinical samples. The first
bacterial isolate was cultured from pleural fluid (Case 1)
while the second isolate was recovered from both cultured
blood and pleural fluid (Case 2). Both patients were
diagnosed with pleural effusion.
The first case involved a 69-year-old male patient with
numerous prior hospitalizations involving chronic isch-
aemic heart disease and grade III gastric adenocarcinoma
(with total gastrectomy 1 year prior to hospitalization). On
admission, the patient presented dysphagia, dyspnoea and
chest pain. Significant findings on physical examination
included dyspnoea [arterial oxygen saturation ,95%], and
severe chest pain exacerbated by deep inspiration,
decreased breath sounds and dullness on percussion over
the right lung. The following tests were performed: blood
workup [haemoglobin, 11 g dl21; platelets, 258 000 ml21;
total white blood cell count, 46109 l21 with a differential
count of 56.2% neutrophils]; C-reactive protein (25.2 mg
l21); creatinine (1.1 mg dl21); and urea (132 mg dl21).
Results indicated normal coagulation profile, blood
glucose, total cholesterol, high-density lipoprotein and
triglycerides. Radiological evaluation of the thorax revealed
slight bilateral pleural effusion.
Diagnostic thoracentesis was performed and 1.2 l pleural
liquid with a serohaematic appearance was extracted. The
clinical materials were submitted for biochemical, micro-
biological and cytological analyses. The biochemistry labor-
atory reported lactate dehydrogenase, 479 UI l21 (quotient
lactate dehydrogenase in pleural liquid/serum .0.6, denot-
ing an exudative nature); the exudate presented a predom-
inance of polymorphonuclear cells, 5.1 g proteins dl21,
88 mg glucose dl21, 30.3 UI adenosine deaminase l21 and
pH of 7.9. The cytological examination did not disclose
atypical cells; however, the microbiological study revealed the
presence of a Gram-negative coccobacillus.
In the second case, an 81-year-old man presented with a fever
of 39 uC, chest pain and coughing for 7 days prior to
hospitalization. Significant findings on physical examination
included dyspnoea (arterial oxygen saturation ,92%), and
severe chest pain exacerbated by deep inspiration, decreased
breath sounds and dullness on percussion over the left lung.
The laboratory analysis revealed: haemoglobin, 12 g dl21;
platelets, 317 000 ml21; total white blood cell count,
11.46109 l21 with a differential count of 91.7% neutrophils;
and C-reactive protein, 600 mg l21. A posteroanterior chest
radiograph revealed a consolidation in the left lung
representing a passive atelectasis with a moderate amount
of left pleural effusion.
A thoracentesis obtained serohaematic fluid, exudative by
lactate dehydrogenase and protein levels (651 UI l21 and 4.4 g
dl21, respectively), with a normal pH (7.4), predominantly
polymorphonuclear cells (90%), an adenosine deaminase level
of 29.6 UI l21 and 135 mg glucose dl21. Atypical cells were not
observed in the cytology analysis but again the microbiological
analysis revealed a Gram-negative coccobacillus.
After thoracentesis, the patients were hospitalized and
levofloxacin (500 mg l21) was administered intravenously.
The GenBank/EMBL/DDBJ accession numbers for the 16S rRNA
sequences of isolates PGE8817 and JGG6850/JGG68502 are
FN658985 and FN658986, respectively.
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This antibiotic was selected according to the clinical
protocol followed in our hospital for this type of
pathology.
Microbiology
In both cases, two sets of blood cultures were drawn
[Becton Dickinson (BD) Bactec 9240 Blood Culture
System]. In Case 1, both sets of aerobic blood culture
bottles yielded a Gram-negative coccobacillus on the fourth
day of hospitalization. In Case 2, the samples in the aerobic
blood culture bottles had not grown by the seventh day of
hospitalization.
In the pleural fluid of both patients, yellow, mucoid,
convex and smooth colonies measuring about 1 mm in
diameter were observed after 5 days of aerobic incubation.
The incubation of pure culture was carried out on sheep
blood agar (5%), chocolate agar and MacConkey agar
(BD).
In both patients, the organism was initially identified using
the BD Phoenix Automated Microbiology System and
MicroScan Walk-Away (Dade Behring). Conventional
biochemical tests showed that the isolates were catalase-
and oxidase-positive and gave a negative result in the
indole test, while the automated methods identified the
strains as Wautersia pauculua (now called Cupriavidus
pauculus) and ‘CDC group EO-2’ (now called Paracoccus
yeei). The isolates showed susceptibility to levofloxacin
(5 mg), ampicillin (10 mg), chloramphenicol (30 mg),
rifampicin (5 mg), tetracycline (30 mg), norfloxacin
(10 mg), novobiocin (30 mg), streptomycin (10 mg),
carbenicillin (100 mg) and erythromycin (15 mg) (BBL
Sensi-Disc Antimicrobial Susceptibility Test Discs; BD).
Susceptibility was assessed by the methods described by the
CLSI (2006, 2008). However, there is no standard
methodology for testing this species for susceptibility.
The patients were administered levofloxacin (500 mg) and
clinical and radiological improvements were observed in
both cases.
The BD Phoenix and MicroScan Walk-Away identification
systems could not provide adequate identification; there-
fore, the isolates were forwarded to another centre for
further characterization.
The three isolates, two from Case 1 and one from Case 2,
were identified as Aurantimonas altamirensis by 16S rRNA
gene sequencing at the Instituto Valenciano de
Microbiologia, Valencia (Betera), Spain, and the Instituto
de Recursos Naturales y Agrobiologia, CSIC, Sevilla, Spain.
The isolates from Case 1 were designated JGG6850 and
JGG68502 (GenBank accession no. FN658986) and the
isolate from Case 2 was designated PGE8817 (GenBank
accession no. FN658985).
The methods used in this study were described previously
by Jurado et al. (2006). Phenotypic characteristics of strains
PGE8817, JGG6850/JGG68502 and A. altamirensis are
shown in Table 1.
Bacterial DNA was extracted following the method described
by Marmur (1961). The 16S rRNA gene was amplified by
PCR using the conserved primers 27F (59-AGA GTT TGA
TCC TGG CTC AG) and 1522R (59-AAG GAGGTG ATC
CAG CCG CA). PCR thermal conditions were as follows:
95 uC for 1 min; 35 cycles of 95 uC for 15 s, 55 uC for 15 s,
72 uC for 2 min; and a final extension cycle at 72 uC for
10 min. Forward and reverse strands of the amplified DNA
fragment were sequenced in an ABI 3700 sequencer (Applied
Biosystems). A similarity search was performed using the
BLAST algorithm (Altschul et al., 1990) at the NCBI database
(National Center for Biotechnology Information; http://www.
ncbi.nlm.nih.gov/). For phylogenetic analysis, nucleotide
Table 1. Phenotypic characteristics of strains PGE8817
(GenBank accession no. FN658985), JGG6850/JGG68502
(GenBank accession no. FN658986) and A. altamirensis
Strains: 1, A. altamirensis CECT 7138T; 2, PGE8817; 3, JGG6850/
JGG68502. 2, Negative; +, positive; (+) weakly positive.
Characteristic 1 2 3
Nitrate reduction 2 2 2
Catalase reaction + + +
Oxidase test + + +
Acid produced from:
D-Arabinose (+) (+) (+)
L-Arabinose + + +
Erythritol + + +
L-Fucose (+) (+) (+)
D-Galactose + + +
Gentiobiose 2 2 2
D-Mannose + + +
Melibiose (+) (+) (+)
L-Rhamnose + + +
D-Ribose + + +
D-Xylose + + +
L-Xylose 2 2 2
Assimilation of:
Arabinose + + +
Glucose + + +
Maltose + + +
Mannitol + + +
Mannose + + +
N-Acetyl-D-glucosamine + + +
Potassium gluconate + + +
Enzymic activity
Alkaline phosphatase + + +
Esterase + + +
Esterase lipase + + +
Leucine arylamidase + + +
Trypsin + + +
Acid phosphatase + + +
Naphthol-AS-BI-phosphohydrolase + + +
Urease + + +
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sequences were aligned using the program CLUSTAL W (Larkin
et al., 2007) with the corresponding sequences of represent-
ative Aurantimonas species from the GenBank (16S rRNA)
database.
Phylogenetic trees were reconstructed using the software
package MEGA3 (Kumar et al., 2004). The overall topologies
of neighbour-joining (Saitou & Nei, 1987), maximum-
likelihood (Felsenstein, 1981) and maximum-parsimony
(Kluge & Farris, 1969) methods were similar (data not
shown). The robustness of the trees was assessed by
bootstrap resampling (1000 replicates). Representative
Aurantimonas strains EU544515, EU442517, EU442518,
EU697964 and EF595814 (Lagrange, 2009; Mendes et al.,
2009; Luong et al., 2008) were found to have 99.4% or
greater similarity to the A. altamirensis type strain
(GenBank accession no. DQ372921). The results of our
phylogenetic analysis showed that these strains fell within
the evolutionary radiation encompassed by the genus
Aurantimonas. In the phylogenetic tree based on the 16S
rRNA gene sequence (Fig. 1), both strains from our cases
formed a clade with the type strain of A. altamirensis,
which is supported by a bootstrap value of 100% in the
neighbour-joining analysis.
Discussion
Both Case 1 and Case 2 were identified as pleural effusion
caused by A. altamirensis. This bacterium belongs to the
‘Aurantimonadaceae’, a small family of marine bacteria; the
first described species was Aurantimonas coralicida, the
causative agent of white plague type II on Caribbean corals
(Denner et al., 2003). A. altamirensis was first isolated in a
subterranean environment, the Altamira Cave (Cantabria,
Spain), from white colonies thriving on the walls of the
cave (Jurado et al., 2006). Furthermore, A. altamirensis was
isolated from human clinical samples from four different
patients in Canada and the USA between 2006 and 2008.
The bacterium was isolated from different clinical samples,
such as: a contact lens and the lens cleansing solution from
a patient with keratitis; culture of corneal scrapings; the
sputum of a cystic fibrosis patient (Luong et al., 2008); and
a bloodstream infection (Mendes et al., 2009).
The clinical relevance of A. altamirensis remains uncertain.
A. altamirensis has not previously been isolated from
pleural effusions, and only one prior report concerning the
respiratory system (cystic fibrosis) has been published
(Luong et al., 2008). The bacterium is considered a
contaminant found in environmental and/or water sources
(Jurado et al., 2006). The clinical symptoms of this disease
appear to be variable, due to the diversity of the reported
pathologies. Moreover, neither the previous reports nor
ours give evidence of any important epidemiological
factors or indicate the possible transmission route of this
bacterium. However, interestingly, recent studies have
revealed that strains closely related to this bacterium have
been isolated from rice plants as plant endophytes and can
be found inside and outside the rice leaves (Mano &
Morisaki, 2008). The patients in this case study live at a
Fig. 1. Phylogenetic tree based on 16S rRNA gene sequences showing the relationships between the isolates obtained from
the patients and an extended set of reference sequences belonging to the genus Aurantimonas. The tree was constructed by
using the neighbour-joining method and was based on a comparison of 1339 nucleotides. The tree was rooted with Fulvimarina
pelagi HTCC 2615T as the outgroup. Bootstrap values are expressed as percentages of 1000 replications. Bar, 0.005
substitutions per nucleotide position. ‘Aurantimonas litoralis’ (AY178863) and ‘Aurantimonas manganoxydans’ (U53824) have
been described by Anderson et al. (2009) but the names have not been validly published to date. GenBank database accession
numbers are given in parentheses.
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distance of some 10 km from each other and at 30 km from
a wetland area with extensive rice production (cities of
Valencia and Albufera), and although direct aetiology
cannot be traced, this coincidence is suggestive.
Immune deficiency associated with AIDS, chemotherapy
for cancer, immune-mediated diseases, transplantation, as
well as ageing of the population, has contributed to the
emergence of infectious diseases in the immunocompro-
mised population. The difficulty of diagnosing patients
with unusual infectious processes, like those caused by A.
altamirensis, and the limitations of automated identifica-
tion systems emphasize the importance of the clinical
diagnosis of rare micro-organisms using molecular bio-
logical techniques. Furthermore, it points to the need for
an epidemiological study of this bacterium, considered a
rare pathogen, within the context of a diversity of
infectious diseases in which it may be involved.
Bacteria from the genus Aurantimonas can be dispersed
through water (Kim et al., 2008; Jurado et al., 2006) and air
(Weon et al., 2007). Isolation of A. altamirensis strains
from environments and patients separated by a consid-
erable geographical distance (Spain, Canada, the USA,
Japan and New Caledonia) indicate that this bacterium
may be of fairly common occurrence. The present study
would indicate that other cases using automated iden-
tification methods may have misidentified A. altamirensis
and, therefore, other A. altamirensis-related cases may
exist.
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